HomeGMED • NYSE
Globus Medical Inc
$87.07
Jan 13, 12:09:40 AM GMT-5 · USD · NYSE · Disclaimer
StockUS listed security
Previous close
$86.55
Day range
$86.41 - $90.48
Year range
$49.33 - $90.48
Market cap
13.81B USD
Avg Volume
850.86K
P/E ratio
131.20
Dividend yield
-
Primary exchange
NYSE
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
625.70M63.10%
Operating expense
305.37M53.23%
Net income
51.84M5,093.99%
Net profit margin
8.283,084.62%
Earnings per share
0.8345.61%
EBITDA
177.50M105.58%
Effective tax rate
9.11%—
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
694.71M48.15%
Total assets
5.09B-5.04%
Total liabilities
1.02B-13.00%
Total equity
4.07B—
Shares outstanding
136.17M—
Price to book
2.89—
Return on assets
5.48%—
Return on capital
6.07%—
Net change in cash
(USD)Sep 2024Y/Y change
Net income
51.84M5,093.99%
Cash from operations
203.65M303.40%
Cash from investing
-14.97M81.49%
Cash from financing
19.58M1,274.25%
Net change in cash
212.34M891.38%
Free cash flow
192.29M136.80%
About
Globus Medical, Inc. is a publicly traded medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders. Wikipedia
Founded
2003
Employees
5,000
Search
Clear search
Close search
Google apps
Main menu